CAYMAN CHEMICAL COMPANY Non-Antibody Products — page 692 of 1
Non-Antibody Products
Page 692 of 1,288
| Name | Description | Size | Catalog # | |
|---|---|---|---|---|
| LPS from Escherichia coli O55:B5 | A form of LPS extracted from wild-type S-form E. coli serotype O55:B5; com… | 2.5 mg | 19660-25 | More Info |
| LPS from Salmonella minnesota R595 (Re) | A rough mutant strain form of LPS extracted from S. minnesota R595 (Re) | 1 mg | 23608-1 | More Info |
| LPS highly purified from Escherichia coli O113 | A form of LPS extracted from wild-type S-form E. coli serotype O113:H10; p… | 1 mg | 19662-1 | More Info |
| L-Pyroglutamic Acid | A cyclized form of L-glutamic acid; L-pyroglutamic acid-Aβ (3-42) agg… | 1 kg | 36531-1 | More Info |
| L-Pyroglutamic Acid | A cyclized form of L-glutamic acid; L-pyroglutamic acid-Aβ (3-42) agg… | 100 g | 36531-100 | More Info |
| L-Pyroglutamic Acid | A cyclized form of L-glutamic acid; L-pyroglutamic acid-Aβ (3-42) agg… | 250 g | 36531-250 | More Info |
| L-Pyroglutamic Acid | A cyclized form of L-glutamic acid; L-pyroglutamic acid-Aβ (3-42) agg… | 500 g | 36531-500 | More Info |
| L-Pyrohomoglutamic Acid | An amino acid building block; has been used in the synthesis of ligands fo… | 1 g | 31694-1 | More Info |
| L-Pyrohomoglutamic Acid | An amino acid building block; has been used in the synthesis of ligands fo… | 5 g | 31694-5 | More Info |
| L-Pyrohomoglutamic Acid | An amino acid building block; has been used in the synthesis of ligands fo… | 500 mg | 31694-500 | More Info |
| L-Quisqualic Acid | A natural analog of glutamate that acts as an agonist at AMPA-selective an… | 1 mg | 20211-1 | More Info |
| L-Quisqualic Acid | A natural analog of glutamate that acts as an agonist at AMPA-selective an… | 10 mg | 20211-10 | More Info |
| L-Quisqualic Acid | A natural analog of glutamate that acts as an agonist at AMPA-selective an… | 25 mg | 20211-25 | More Info |
| L-Quisqualic Acid | A natural analog of glutamate that acts as an agonist at AMPA-selective an… | 5 mg | 20211-5 | More Info |
| LQZ-7I | An inhibitor of survivin; inhibits survivin dimerization in a SEAP assay u… | 100 mg | 36602-100 | More Info |
| LQZ-7I | An inhibitor of survivin; inhibits survivin dimerization in a SEAP assay u… | 25 mg | 36602-25 | More Info |
| LQZ-7I | An inhibitor of survivin; inhibits survivin dimerization in a SEAP assay u… | 250 mg | 36602-250 | More Info |
| LQZ-7I | An inhibitor of survivin; inhibits survivin dimerization in a SEAP assay u… | 50 mg | 36602-50 | More Info |
| LRRK2-IN-1 | A potent, selective inhibitor of LRRK2 that inhibits both wild-type and G2… | 1 mg | 18094-1 | More Info |
| LRRK2-IN-1 | A potent, selective inhibitor of LRRK2 that inhibits both wild-type and G2… | 10 mg | 18094-10 | More Info |
| LRRK2-IN-1 | A potent, selective inhibitor of LRRK2 that inhibits both wild-type and G2… | 5 mg | 18094-5 | More Info |
| LRRKtide (trifluoroacetate salt) | A peptide substrate for LRRK2; has been used to identify inhibitors of LRR… | 1 mg | 37461-1 | More Info |
| LRRKtide (trifluoroacetate salt) | A peptide substrate for LRRK2; has been used to identify inhibitors of LRR… | 10 mg | 37461-10 | More Info |
| LRRKtide (trifluoroacetate salt) | A peptide substrate for LRRK2; has been used to identify inhibitors of LRR… | 25 mg | 37461-25 | More Info |
| LRRKtide (trifluoroacetate salt) | A peptide substrate for LRRK2; has been used to identify inhibitors of LRR… | 5 mg | 37461-5 | More Info |
| LSD | An analytical reference standard categorized as a lysergamide; has halluci… | 1 mg | 37037-1 | More Info |
| LSD | An analytical reference standard categorized as a lysergamide; has halluci… | 5 mg | 37037-5 | More Info |
| LSD1 Inhibitor Screening Assay Kit | LSD1 is a histone demethylase whose actions on specific lysine residues al… | 96 Well | 700120-96WELLS | More Info |
| L-Selectin/CD62L Extracellular Domain (human, recombinant) | Source: Recombinant human C-terminal His-tagged L-selectin expressed in CH… | 200 µg | 35509-200 | More Info |
| L-Selectin/CD62L Extracellular Domain (mouse, recombinant) | Source: Active recombinant C-terminal human IgG1 Fc-His-tagged mouse L-sel… | 100 µg | 35727-100 | More Info |
| L-Selenocystine | A diselenide-bridged amino acid that has both anti- and pro-oxidant action… | 1 g | 17793-1 | More Info |
| L-Selenocystine | A diselenide-bridged amino acid that has both anti- and pro-oxidant action… | 100 mg | 17793-100 | More Info |
| L-Selenocystine | A diselenide-bridged amino acid that has both anti- and pro-oxidant action… | 250 mg | 17793-250 | More Info |
| L-Selenocystine | A diselenide-bridged amino acid that has both anti- and pro-oxidant action… | 50 mg | 17793-50 | More Info |
| L-Selenomethionine | The predominant form of selenium found in Brazil nuts, grains, soy beans,… | 1 g | 16005-1 | More Info |
| L-Selenomethionine | The predominant form of selenium found in Brazil nuts, grains, soy beans,… | 100 mg | 16005-100 | More Info |
| L-Selenomethionine | The predominant form of selenium found in Brazil nuts, grains, soy beans,… | 250 mg | 16005-250 | More Info |
| L-Serine | A non-essential amino acid; produced from 3-phosphoglycerate in a multiste… | 100 g | 33561-100 | More Info |
| L-Serine | A non-essential amino acid; produced from 3-phosphoglycerate in a multiste… | 25 g | 33561-25 | More Info |
| L-Serine | A non-essential amino acid; produced from 3-phosphoglycerate in a multiste… | 250 g | 33561-250 | More Info |
| L-Serine | A non-essential amino acid; produced from 3-phosphoglycerate in a multiste… | 50 g | 33561-50 | More Info |
| L-Serine-13C3 | An internal standard for the quantification of L-serine by GC- or LC-MS | 1 mg | 35126-1 | More Info |
| L-Serine-13C3 | An internal standard for the quantification of L-serine by GC- or LC-MS | 5 mg | 35126-5 | More Info |
| L-Serine-13C3 | An internal standard for the quantification of L-serine by GC- or LC-MS | 500 µg | 35126-500 | More Info |
| L-Serine-d7 | An internal standard for the quantification of L-serine by GC- or LC-MS | 10 mg | 34827-10 | More Info |
| L-Serine-d7 | An internal standard for the quantification of L-serine by GC- or LC-MS | 25 mg | 34827-25 | More Info |
| L-Serine-d7 | An internal standard for the quantification of L-serine by GC- or LC-MS | 5 mg | 34827-5 | More Info |
| L-Serine-d7 | An internal standard for the quantification of L-serine by GC- or LC-MS | 50 mg | 34827-50 | More Info |
| LSN2463359 | A brain penetrant positive allosteric modulator of the mGluR5 (EC50 = 24 n… | 1 mg | 22104-1 | More Info |
| LSN2463359 | A brain penetrant positive allosteric modulator of the mGluR5 (EC50 = 24 n… | 10 mg | 22104-10 | More Info |
CAYMAN CHEMICAL COMPANY
CAYMAN CHEMICAL COMPANY
1180 East Ellsworth Road
Ann Arbor MI 48108
P: (734) 971-3335
P: (800) 364-9897 (USA & Canada only)
F: (734) 971-3640
Customer Service: custserv@caymanchem.com
Technical Support: techserv@caymanchem.com
Sales: sales@caymanchem.com
http://www.caymanchem.com
Return to Profile